Author

J. W. Park

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Approach:statistical model· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

A. Xavier· 1 shared B. Akosman· 1 shared B. Alejandro· 1 shared C. Cadena· 1 shared C. G. Lee· 1 shared C.-C. Chen· 1 shared C.-M. Lee· 1 shared D. Cheng· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 8 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Xavier

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

PGC-1a drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacity

G. Varuzhanyan, C.-C. Chen, J. Freeland, T. He, W. Tran, K. Song, L. Wang, D. Cheng, S. Xu, G. A. Dibernardo, F. N. Esedebe, V. Bhatia, M. Han, E. R. Abt, J. W. Park, , O. N. Witte

bioRxiv · Apr 9, 2024Cancer Biology

Non-catastrophic collapse of VEEV by lethal mutagenesis

B. Alejandro, E. J. Kim, J. Y. Hwang, J. W. Park, M. Smith, D. Chung

This study investigates how Venezuelan Equine Encephalitis Virus (VEEV) responds to RNA mutagen treatment, finding that replication-competent subpopulations persist with lower mutation frequency and increased adaptability.

bioRxiv · Jun 21, 2022 · PreprintMicrobiology

Kasugamycin is a novel chitinase 1 inhibitor with strong antifibrotic effects on pulmonary fibrosis

J.-H. Lee, C.-M. Lee, J. H. Lee, M.-O. Kim, J. W. Park, S. Kamle, B. Akosman, E. L. Herzog, X. Y. Peng, J. A. Elias, C. G. Lee

This study identifies Kasugamycin as a novel CHIT1 inhibitor with strong antifibrotic effects in pulmonary fibrosis models.

bioRxiv · Feb 25, 2021Immunology

Ubiquitin-dependent and -independent roles of E3 ligase RIPLET in innate immunity

C. Cadena, S. Ahmad, A. Xavier, J. Willemsen, S. Park, J. W. Park, S.-W. Oh, T. Fujita, F. Hou, M. Binder, S. Hur

RIPLET functions as a molecular glue to assemble signaling scaffolds for the antiviral innate immune receptor RIG-I.

bioRxiv · Mar 7, 2019Immunology